OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

TEXAS INSTRUMENTS INC (TXN) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TXN · TEXAS INSTRUMENTS INC

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters
Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 4 filings · fetched 2026-11-13T20:20:13Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page
6sale rows on this page
14matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F2

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative6,065D0DirectForm 4 ↗0000097476-26-000178
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F1

S Sale (market/private)Common Stock · Non-derivative6,065D310.39DirectForm 4 ↗0000097476-26-000178
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References:

M Exercise / conversionCommon Stock · Non-derivative6,065A79.26DirectForm 4 ↗0000097476-26-000178
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F3

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative6,065D0DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F2

S Sale (market/private)Common Stock · Non-derivative477D303.07DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F1

S Sale (market/private)Common Stock · Non-derivative5,588D302.14DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References:

M Exercise / conversionCommon Stock · Non-derivative6,065A79.26DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References: F2

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative4,532D0DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References: F1

S Sale (market/private)Common Stock · Non-derivative4,532D301.56DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References:

M Exercise / conversionCommon Stock · Non-derivative4,532A104.41DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F3

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative4,306D0DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F2

S Sale (market/private)Common Stock · Non-derivative350D303.17DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F1

S Sale (market/private)Common Stock · Non-derivative3,956D302.4DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References:

M Exercise / conversionCommon Stock · Non-derivative4,306A110.15DirectForm 4 ↗0000097476-26-000176

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.